E-cigarette or vaping fluid

Abstract

Improved vaping fluids for energy boos, relaxation, appetite and other functions contain active ingredients combined with cyclodextrin to enhance absorption and avoid irritation. Active ingredients include caffeine, theophylline, yerba mate and valerian as well as taurine, carnitine and L-tryptophan. The active ingredients are combined with an aqueous solution of hydrophilic solvents (such as glycerin or propylene glycol) as well as traces of scents or flavors.

What is claimed is: 
     
         1 . An e-fluid for use in an e-cigarette or similar device comprising:
 caffeine at a concentration of between about 0.01M to about 0.15M;   cyclodextrin at a concentration having a molar ratio with the caffeine concentration of 0.5 to 5.0; and   an aqueous solution of hydrophilic solvent being between about 2M and 10M hydrophilic solvent.   
     
     
         2 . The e-fluid of  claim 1  wherein the hydrophilic solvent is selected from the group consisting of glycerol and propylene glycol. 
     
     
         3 . The e-fluid of  claim 1  further comprising carnitine at a concentration of about 0.01% and about 0.5% volume by volume. 
     
     
         4 . The e-fluid of  claim 1  further comprising taurine at a concentration of between about 0.01M and about 0.1M. 
     
     
         5 . The e-fluid of  claim 1  further comprising cyanocobalamin at a concentration of between about 0.01% weight by volume and 0.1% weight by volume. 
     
     
         6 . An e-fluid for use in an e-cigarette or similar device comprising:
 valerian extract at a concentration of between about 0.01% and about 0.5% volume by volume;   cyclodextrin at a concentration having a molar ratio with the valerian extract concentration of 0.5 to 5.0; and   an aqueous solution of hydrophilic solvent being between about 2M and 10M hydrophilic solvent.   
     
     
         7 . The e-fluid of  claim 6  wherein the hydrophilic solvent is selected from the group consisting of glycerol and propylene glycol. 
     
     
         8 . The e-fluid of  claim 6  further comprising L-tryptophan at a concentration of about 0.01% and about 0.5% weight by volume. 
     
     
         9 . The e-fluid of  claim 6  further comprising extract of chamomile at a concentration of about 0.01% and about 0.5% volume by volume. 
     
     
         10 . The e-fluid of  claim 6  further comprising cyanocobalamin at a concentration of between about 0.01% weight by volume and 0.1% weight by volume. 
     
     
         11 . An e-fluid for use in an e-cigarette or similar device comprising:
 nicotine at a concentration of between about 0.01 M to about 0.2M;   cyclodextrin at a concentration having a molar ratio with the nicotine concentration of 0.5 to 5.0; and   an aqueous solution of hydrophilic solvent being between about 2M and 10M hydrophilic solvent.   
     
     
         12 . The e-fluid of  claim 11  wherein the hydrophilic solvent is selected from the group consisting of glycerol and propylene glycol. 
     
     
         13 . The e-fluid of  claim 11  further comprising taurine at a concentration of between about 0.01M to about 0.1M. 
     
     
         14 . The e-fluid of  claim 11  further comprising cyanocobalamin at a concentration of between about 0.01% weight by volume and 0.1% weight by volume.